BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27764998)

  • 1. Helicobacter pylori participates in the pathogenesis of IgA nephropathy.
    Zhu TT; Wang L; Wang HL; He Y; Ma X; Fan JM
    Ren Fail; 2016 Oct; 38(9):1398-1404. PubMed ID: 27764998
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Liu XZ; Zhang YM; Jia NY; Zhang H
    Ren Fail; 2020 Nov; 42(1):539-546. PubMed ID: 32524871
    [No Abstract]   [Full Text] [Related]  

  • 3. CagA, a major virulence factor of Helicobacter pylori, promotes the production and underglycosylation of IgA1 in DAKIKI cells.
    Yang M; Li FG; Xie XS; Wang SQ; Fan JM
    Biochem Biophys Res Commun; 2014 Feb; 444(2):276-81. PubMed ID: 24462875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy.
    Barratt J; Bailey EM; Buck KS; Mailley J; Moayyedi P; Feehally J; Turney JH; Crabtree JE; Allen AC
    Am J Kidney Dis; 1999 Jun; 33(6):1049-57. PubMed ID: 10352192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
    Smith AC; Molyneux K; Feehally J; Barratt J
    J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there any association between IgA nephropathy, Crohn's disease and Helicobacter pylori infection?
    Pipili C; Michopoulos S; Sotiropoulou M; Mpakirtzi T; Grapsa E
    Ren Fail; 2012; 34(4):506-9. PubMed ID: 22260406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Haemophilus parainfluenzae antigens in IgA nephropathy].
    Suzuki S; Kimura H; Gejyo F
    Rinsho Byori; 1998 Jan; 46(1):17-25. PubMed ID: 9492534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of anti-Helicobacter pylori antibodies in Henoch-Schönlein purpura.
    Novák J; Szekanecz Z; Sebesi J; Takáts A; Demeter P; Bene L; Sipka S; Csiki Z
    Autoimmunity; 2003 Aug; 36(5):307-11. PubMed ID: 14567560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.
    Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM
    Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coccoid Helicobacter pylori exists in the palatine tonsils of patients with IgA nephropathy.
    Kusano K; Inokuchi A; Fujimoto K; Miyamoto H; Tokunaga O; Kuratomi Y; Shimazu R; Mori D; Yamasaki F; Kidera K; Tsunetomi K; Miyazaki J
    J Gastroenterol; 2010 Apr; 45(4):406-12. PubMed ID: 19997853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
    Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori antigen and its IgG, IgA -type specific immunocomplexes in sera from patients with Helicobacter pylori infection.
    Zhu Y; Lin J; Li D; Du Q; Qian K; Wu Q; Zheng S
    Chin Med J (Engl); 2002 Mar; 115(3):381-3. PubMed ID: 11940370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
    Ławniczak M; Starzyńska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between the CagA Antigen and Serum Levels of Anti-Helicobacter pylori IgG and IgA in Children.
    Seo JH; Lim CW; Park JS; Yeom JS; Lim JY; Jun JS; Woo HO; Youn HS; Baik SC; Lee WK; Cho MJ; Rhee KH
    J Korean Med Sci; 2016 Mar; 31(3):417-22. PubMed ID: 26955243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with IgA nephropathy respond strongly through production of IgA with low avidity against Staphylococcus aureus.
    Shimizu Y; Seki M; Kaneko S; Hagiwara M; Yoh K; Yamagata K; Koyama A
    Contrib Nephrol; 2007; 157():139-43. PubMed ID: 17495452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial IgA protease-mediated degradation of agIgA1 and agIgA1 immune complexes as a potential therapy for IgA Nephropathy.
    Wang L; Li X; Shen H; Mao N; Wang H; Cui L; Cheng Y; Fan J
    Sci Rep; 2016 Aug; 6():30964. PubMed ID: 27485391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prevalence of Helicobacter pylori infection among the Georgian population].
    Girdaladze AM; Mosidze BA; Tsertsvadze TN; Shartava TsK; Girdaladze SA
    Georgian Med News; 2008 Apr; (157):34-9. PubMed ID: 18487688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparity between mucosal and serum IgA and IgG in Helicobacter pylori infection.
    Schmausser B; Eck M; Greiner A; Lührs H; Vollmers HP; Müller-Hermelink HK
    Virchows Arch; 2002 Aug; 441(2):143-7. PubMed ID: 12189503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The landscape and diagnostic potential of T and B cell repertoire in Immunoglobulin A Nephropathy.
    Huang C; Li X; Wu J; Zhang W; Sun S; Lin L; Wang X; Li H; Wu X; Zhang P; Xu G; Wang H; Liu H; Liu Y; Chen D; Zhuo L; Li W; Yang H; Wang J; Wang L; Liu X
    J Autoimmun; 2019 Feb; 97():100-107. PubMed ID: 30385082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.